JP Morgan Downgrades Sotera Health to Underweight, Announces $17 Price Target
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsDowngradesPrice Target
JP Morgan analyst Casey Woodring downgrades Sotera Health (NASDAQ:SHC) from Neutral to Underweight and announces $17 price target.
JP Morgan analyst Casey Woodring downgrades Sotera Health (NASDAQ:SHC) from Neutral to Underweight and announces $17 price target.